Alarming figures laying bare the 'baby bust' reveal some boroughs have seen a 60 per cent decline in women having children ...

Skye Bioscience, Inc. (NASDAQ:SKYE) is at a critical juncture in its development of nimacimab, a novel CB1 receptor inhibitor for obesity treatment. As the company progresses through clinical ...

The acquisition includes a preclinical-stage drug candidate, SKNY-1, targeting obesity and smoking cessation. The binding letter of intent (LOI) for the acquisition was signed today, and the ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

BOSTON - Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a $3.4 billion biopharmaceutical company specializing in rare neuroendocrine diseases, has reclaimed the rights to its obesity drug ...

A new map has revealed the most common religion in every African country, showing a clear divide between Christianity and ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

AFP becomes one of the main source for international news. We've got various news from around the world. I can say that AFP news content is diverse and credible, and they can fit with the ...

A new World Bank report shows that poverty in Africa may be lower than current estimates suggest and no systematic increase in inequality, given the available data Challenges remain substantial: more ...

These types of deaths are known ... Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target ...